Quantitative Heritability of Anti-Citrullinated Protein Antibody-Positive and Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis

Leiden University Medical Center, Leiden, The Netherlands.
Arthritis & Rheumatology (Impact Factor: 7.76). 05/2009; 60(4):916-23. DOI: 10.1002/art.24385
Source: PubMed


The majority of genetic risk factors for rheumatoid arthritis (RA) are associated with anti-citrullinated protein antibody (ACPA)-positive RA, while far fewer genetic risk factors have been identified for ACPA-negative RA. This study was undertaken to quantify the contribution of genetic risk factors in general, and of the predisposing HLA-DRB1 shared epitope (SE) alleles in particular, to the ACPA-positive and ACPA-negative subsets of RA, by computing their heritability and assessing the contribution of the HLA SE alleles.
One hundred forty-eight RA twin pairs, in which at least 1 twin of each pair had RA, were tested for ACPAs and typed for HLA-DRB1 genotypes. Heritability was assessed in a logistic regression model including a bivariate, normally distributed random effect, representing the contribution of unobserved genetic factors to RA susceptibility, with the correlation of the random effects fixed according to twin zygosity. The contribution of the HLA SE alleles to genetic variance was assessed using a similar model, except that estimates were based on genotype-specific population prevalences.
The heritability of RA among the twin pairs was 66% (95% confidence interval [95% CI] 44-75%). For ACPA-positive RA, the heritability was 68% (95% CI 55-79%), and for ACPA-negative RA it was 66% (95% CI 21-82%). Presence of the HLA SE alleles explained 18% (95% CI 16-19%) of the genetic variance of ACPA-positive RA but only 2.4% (95% CI 1.6-10%) of the genetic variance of ACPA-negative RA.
The heritability of ACPA-positive RA is comparable with that of ACPA-negative RA. These data indicate that genetic predisposition plays an important role in the pathogenesis of ACPA-negative RA, for which most individual genetic risk factors remain to be identified.

8 Reads
    • "Heritability estimates of autoantibody positive individuals are similar to autoantibody negative individuals (~40e50%) indicating a significant contribution of genetic factors to both subgroups [8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The last decade has seen a dramatic technological revolution. The characterisation of the majority of the common variations in our genetic code in 2003 precipitated the discovery of the genetic risk factors predisposing to Rheumatoid Arthritis development and progression. Prior to 2007, only a handful of genetic risk factors had been identified, HLA, PTPN22 and CTLA4. Since then, over 100 genetic risk loci have been described, with the prediction that an ever-increasing number of risk alleles with consistently decreasing effect sizes will be discovered in the years to come. Each risk locus harbours multiple candidate genes and the proof of causality of each of these candidates is as yet unknown. An enrichment of these RA-associated genes is found in three pathways: T-cell receptor signalling, JAK-STAT signalling and the NF-κB signalling cascade, and currently drugs targeting these pathways are available for the treatment of RA. However, the role that RA-associated genes have in these pathways and how they contribute to disease is not always clear. Major efforts in understanding the contribution of genetic risk factors are currently under way with studies querying the role of genetic variation in gene expression of coding and non-coding genes, epigenetic marks and other regulatory mechanisms yielding ever more valuable insights into mechanisms of disease. Recent work has suggested a possible enrichment of non-coding RNAs as well as super-enhancers in RA genetic loci indicating possible new insights into disease mechanism. This review brings together these emerging genetic data with an emphasis on the immunogenetic links these findings have provided and what we expect the future will bring. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Journal of Autoimmunity 07/2015; 64. DOI:10.1016/j.jaut.2015.07.007 · 8.41 Impact Factor
  • Source
    • "SE alleles, lymphoid-specific tyrosine phosphatase (LYP)/protein tyrosine phosphatase, nonreceptor type (PTPN) 22, and cigarette smoking are risk factors for the development of ACPA positive RA patients [47] [60]. Further, it has been reported that also the noninherited maternal HLA antigens (NIMA), originally discovered in transplantation immunology [61], containing the RA-protective DERAA sequence, protect DERAA-negative children against RA [49] [62]. It has been recently reported that the gene polymorphism may not only be associated with the pathogenesis of SAIRDs, but also with the outcome of the treatment and the progression of the disease. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Systemic autoimmune and rheumatic diseases (SAIRDs) are thought to develop due to the failure of autoimmune regulation and tolerance. Current therapies, such as biologics, have improved the clinical results of SAIRDs; however, they are not curative treatments. Recently, new discoveries have been made in immune tolerance and inflammation, such as tolerogenic dendritic cells, regulatory T and B cells, Th 17 cells, inflammatory and tolerogenic cytokines, and intracellular signaling pathways. They lay the foundation for the next generation of the therapies beyond the currently used biologic therapies. New drugs should target the core processes involved in disease mechanisms with the aim to attain complete cure combined with safety and low costs compared to the biologic agents. Re-establishment of autoimmune regulation and tolerance in SAIRDs by the end of the current decade should be the final and realistic target.
    Clinical and Developmental Immunology 01/2012; 2012(1740-2522):941346. DOI:10.1155/2012/941346 · 2.93 Impact Factor
  • Source
    • "Autoimmunity to citrullinated proteins is highly specific for RA and may be of pathogenic significance [24]. Risk of developing RA is of 50% attributable to genetic factors [25]. Smoking is the major known environmental risk factor for RA. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Rheumatoid Arthritis (RA) and chronic and aggressive periodontitis are chronic inflammatory disorders characterized by deregulation of the host inflammatory response. Increased secretion of pro-inflammatory mediators results in soft and hard tissue destruction of the synovium and periodontium respectively. Both diseases share risk factors and have pathological pathways in common, resulting in loss of function and disability as a final clinical outcome. This article discusses possible interactions, particularly related to the periodontal pathogen Porphyromonas gingivalis, which could explain the observed association between these two prevalent diseases.
    Anaerobe 04/2011; 17(4):196-200. DOI:10.1016/j.anaerobe.2011.03.019 · 2.48 Impact Factor
Show more